Latest News

Written by: http://www.theneweconomy.com/technology/volcano-corporations-imaging-technologi…
Volcano Europe’s imaging technologies help cut heart disease
CVRx Barostim neo Now Cleared for MRI Use in Europe
Written by: cardionovum
Cardionovum® begins clinical study of APERTO® Drug Coated Balloon (DCB), designed for long-term prevention…
Written by: directflowmedical
DIRECT FLOW MEDICAL® ANNOUNCES NEW FINANCING OF $32 MILLION
Written by: REVA
REVA Implants First Patients with Fantom Scaffold
Written by: Biotronik
BIOTRONIK Releases New Online Tool to Track MR Conditional Status of Implantable Devices
Written by: http://chronic-comm.com/
BIOCARDIA®, INC. ANNOUNCES FDA ACCEPTANCE OF PHASE III CLINICAL TRIAL PROTOCOL STUDYING BONE MARROW-DERIVED…
OPSENS GRANTED CE MARKING FOR SALE OF FFR PRODUCTS IN EUROPE
Written by: globenewswire.com
nContact Secures $20 Million in Growth Capital Financing
Written by: Abbott
ABBOTT EXPANDS ITS MEDICAL DEVICE BUSINESS WITH ACQUISITION IN CATHETER-BASED ELECTROPHYSIOLOGY MARKET

External news

Written by: Cardiac Vascular News
HeartX Cardiovascular Accelerator Announces Four Startup Companies Selected for the 2024 Program
Written by: Cardiac Vascular News
Argon Medical Announces the Expansion of Liver Management Portfolio with Two New Product Introductions
Written by: Cardiac Vascular News
Windtree Announces Positive Phase 2b Topline Clinical Results with Istaroxime Significantly Improving Cardiac Function and Blood Pressure in Heart Failure Patients in Early Cardiogenic Shock
Written by: Cardiac Vascular News
Cortechs.ai Announces Strategic Partnership with Ascend Imaging to Expand Access to Cutting-Edge Radiology Solutions
Written by: Cardiovascular Business
FDA approves GE HealthCare's flurpiridaz F-18 PET radiotracer for CAD
Written by: Cardiovascular Business
With AFib ablation on the rise, HRS highlights importance of proper EP training
Written by: Cardiovascular Business
Reduced LVEF before TAVR linked to lower long-term survival rate
Written by: Cardiovascular Business
Heart Failure Society of America to livestream late-breaking studies after meeting cancellation
Written by: Cardiac Vascular News
BridgeBio Shares Recurrent Event Analysis of ATTRibute-CM, Demonstrating a 42% Reduction by Acoramidis on the Composite Endpoint of All-Cause Mortality and Recurrent Cardiovascular-related Hospitalization Events
Written by: Medscape
Sep 27 2024 This Week in Cardiology